ZUEINO™ (diclofenac sodium) injection is now FDA approved.ZUEINO™ is now FDA approved. See Zueino
Adventa PharmaAdvancing Proven Medicines

Portfolio Approved products, commercialised through partners

Adventa Pharma’s approved ANDAs and 505(b)(2) products are partnered with established US commercial companies. Zueino is our most recent approval.

ProductPathwayDevelopment stageCommercial status
Sole-supplier generic portfolioComplex and limited-competition productsANDA
DevelopFileApprovedMarketed
Partnered in the US
505(b)(2) productsImproved formulations of approved medicines505(b)(2) NDA
DevelopFileApprovedMarketed
Partnered in the US
Zueino™diclofenac sodium injection505(b)(2) NDA
DevelopFileApprovedMarketed
Approved
Development pipelineNew ANDAs and 505(b)(2) programmesANDA · 505(b)(2)
DevelopFileApprovedMarketed
Partnering discussions open

Swipe the table sideways to see every column.